HDAC-IN-38

Modify Date: 2025-08-26 09:39:58

HDAC-IN-38 Structure
HDAC-IN-38 structure
Common Name HDAC-IN-38
CAS Number 2408123-36-2 Molecular Weight 461.98
Density N/A Boiling Point N/A
Molecular Formula C27H28ClN3O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HDAC-IN-38


HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].

 Names

Name HDAC-IN-38

 HDAC-IN-38 Biological Activity

Description HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].
Related Catalog
Target

HDAC8:0.533 μM (IC50)

HDAC6:1.27 μM (IC50)

HDAC3:2.86 μM (IC50)

HDAC1:3.82 μM (IC50)

HDAC5:6.27 μM (IC50)

HDAC2:6.62 μM (IC50)

References

[1]. Kaur N, et al. Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment. Eur J Med Chem. 2020 Feb 1;187:111915.

 Chemical & Physical Properties

Molecular Formula C27H28ClN3O2
Molecular Weight 461.98
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.